Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis
Efstathios Kastritis(National and Kapodistrian University of Athens), Giovanni Palladini(University of Pavia), Erasmia Psimenou, Μαρία Ρούσσου(National and Kapodistrian University of Athens), Evangelos Eleutherakis‐Papaiakovou(National and Kapodistrian University of Athens), Marco Basset(University of Pavia), Meletios Α. Dimopoulos(Korea University), Evangelos Terpos(National and Kapodistrian University of Athens), Dimitrios C. Ziogas(National and Kapodistrian University of Athens), Paolo Milani(University of Pavia), Giampaolo Merlini(University of Pavia), Maria Gavriatopoulou(National and Kapodistrian University of Athens), Despina Fotiou(National and Kapodistrian University of Athens), Francesca Russo(Policlinico Umberto I), Elektra Papadopoulou(National and Kapodistrian University of Athens), Athanasios Akalestos(Roche (Greece)), Filia Apostolakou(Children's Hospital Agia Sophia), Constantinos Pamboucas(National and Kapodistrian University of Athens), Ioannis Papassotiriou(National and Kapodistrian University of Athens)
Cited by 67
Related Papers
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k